NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 32 filers reported holding NEUROBO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $45,000 | -86.6% | 93,376 | -75.0% | 0.03% | -38.0% |
| Q1 2022 | $337,000 | -60.9% | 373,111 | -47.2% | 0.05% | -60.0% |
| Q4 2021 | $862,000 | +15.2% | 706,946 | +396.5% | 0.12% | -12.6% |
| Q4 2020 | $748,000 | -27.1% | 142,400 | -22.0% | 0.14% | -6.5% |
| Q3 2020 | $1,026,000 | -45.2% | 182,543 | -21.5% | 0.15% | -59.3% |
| Q2 2020 | $1,872,000 | – | 232,547 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $191,000 | 0.02% |
| FNY Investment Advisers, LLC | 10,000 | $33,000 | 0.01% |
| SG3 Management, LLC | 50,000 | $167,000 | 0.01% |
| PITCAIRN CO | 12,351 | $41,000 | 0.00% |
| Ergoteles LLC | 30,800 | $103,000 | 0.00% |
| Advisory Services Network, LLC | 8,550 | $28,000 | 0.00% |
| HRT FINANCIAL LP | 18,759 | $62,000 | 0.00% |
| UBS Group AG | 2,881 | $10,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,062 | $4,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 320 | $1,000 | 0.00% |